The aim of the Leukemia Program is to improve the prognosis of patients with leukemia through basic research, clinical investigation, and outcomes studies. To this end, the program has assembled laboratory researchers, translational scientists, clinical investigators interested in pathogenesis, epidemiology, or treatment of adult and pediatric patients with acute leukemias, myeloproliferative disorders, myelodysplasia, and related diseases.